Folgen
Ulf Andersson
Ulf Andersson
Head of Preclincal Safety and Translational Pharmacology
Bestätigte E-Mail-Adresse bei debiopharm.com
Titel
Zitiert von
Zitiert von
Jahr
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
Z Wu, P Puigserver, U Andersson, C Zhang, G Adelmant, V Mootha, ...
Cell 98 (1), 115-124, 1999
47501999
Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells
U Andersson, RC Scarpulla
Molecular and cellular biology, 2001
4922001
Isoforms of alanine aminotransferases in human tissues and serum—differential tissue expression using novel antibodies
P Lindblom, I Rafter, C Copley, U Andersson, JJ Hedberg, AL Berg, ...
Archives of biochemistry and biophysics 466 (1), 66-77, 2007
1482007
Who watches the watchmen? Regulation of the expression and activity of sirtuins
M Buler, U Andersson, J Hakkola
The FASEB Journal 30 (12), 3942-3960, 2016
982016
The Expression of Subunit c Correlates with and Thus May Limit the Biosynthesis of the Mitochondrial F0F1-ATPase in Brown Adipose Tissue (∗)
J Houstek, U Andersson, P Tvrdík, J Nedergaard, B Cannon
Journal of Biological Chemistry 270 (13), 7689-7694, 1995
961995
Mitochondrial ATP synthase levels in brown adipose tissue are governed by the c‐Fo subunit P1 isoform
TV Kramarova, IG Shabalina, U Andersson, R Westerberg, I Carlberg, ...
The FASEB Journal 22 (1), 55-63, 2008
922008
An oral antisense oligonucleotide for PCSK9 inhibition
P Gennemark, K Walter, N Clemmensen, D Rekić, CAM Nilsson, ...
Science Translational Medicine 13 (593), eabe9117, 2021
882021
The conundrum of GSK3 inhibitors: is it the dawn of a new beginning?
RV Bhat, U Andersson, S Andersson, L Knerr, U Bauer, ...
Journal of Alzheimer's Disease 64 (s1), S547-S554, 2018
792018
PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes
P Thulin, I Rafter, K Stockling, C Tomkiewicz, E Norjavaara, M Aggerbeck, ...
Toxicology and applied pharmacology 231 (1), 1-9, 2008
782008
Correlation network analysis for data integration and biomarker selection
A Adourian, E Jennings, R Balasubramanian, WM Hines, D Damian, ...
Molecular BioSystems 4 (3), 249-259, 2008
712008
GSK-3 inhibition by an orally active small molecule increases bone mass in rats
R Marsell, G Sisask, Y Nilsson, AK Sundgren-Andersson, U Andersson, ...
Bone 50 (3), 619-627, 2012
682012
A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran
U Andersson, J Lindberg, S Wang, R Balasubramanian, ...
Biomarkers 14 (8), 572-586, 2009
662009
Dynein light chain interacts with NRF-1 and EWG, structurally and functionally related transcription factors from humans and Drosophila
RP Herzig, U Andersson, RC Scarpulla
Journal of cell science 113 (23), 4263-4273, 2000
652000
ATP synthase subunit c expression: physiological regulation of the P1 and P2 genes
U ANDERSSON, J HOUŠTĚK, B CANNON
Biochemical Journal 323 (2), 379-385, 1997
581997
Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
M Liljevald, M Rehnberg, M Söderberg, M Ramnegård, J Börjesson, ...
Autoimmunity reviews 15 (11), 1062-1070, 2016
522016
Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism
C Danielsson, J Brask, AC Sköld, R Genead, A Andersson, U Andersson, ...
Cardiovascular research 97 (1), 23-32, 2013
492013
Tesaglitazar, a PPARα/γ agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats
H Hellmold, H Zhang, U Andersson, B Blomgren, T Holland, AL Berg, ...
Toxicological Sciences 98 (1), 63-74, 2007
382007
Unifying and distinguishing features of brown and white adipose tissues: UCP1 versus other UCPs
B Cannon, A Matthias, V Golozoubova, KBE Ohlson, U Andersson, ...
Progress in Obesity Research 8, 13-26, 1999
261999
Use of Toxicogenomics in Drug Safety Evaluation: Current Status and an Industry Perspective
SDP Vahle, JL, Andersson, U, Blomme EAG, Hoflack JC
Regul Toxicol Pharmacol 96, 2018
222018
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl …
M Munck af Rosenschöld, P Johannesson, A Nikitidis, C Tyrchan, ...
Journal of Medicinal Chemistry 62 (17), 7769-7787, 2019
172019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20